Sunrun (NASDAQ:RUN – Get Free Report) had its target price lowered by investment analysts at Susquehanna from $24.00 to $19.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has a “positive” rating on the energy company’s stock. Susquehanna’s price target would indicate a potential upside of 39.89% from […]

Newell Brands (NASDAQ:NWL – Get Free Report) had its price objective cut by equities research analysts at UBS Group from $5.00 to $3.75 in a report released on Tuesday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s target price would suggest a potential upside of 5.19% from the company’s previous […]

GCM Grosvenor (NASDAQ:GCMG – Get Free Report) had its price target lowered by investment analysts at Piper Sandler from $14.50 to $13.00 in a report issued on Tuesday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Piper Sandler’s price target indicates a potential upside of 35.35% from the company’s current price. Other […]

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its target price lifted by Wedbush from $151.00 to $166.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Wedbush’s target price would suggest a potential upside of 25.30% from the company’s current price. […]

Patterson-UTI Energy (NASDAQ:PTEN – Get Free Report) had its target price raised by Susquehanna from $10.00 to $13.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “positive” rating on the oil and gas company’s stock. Susquehanna’s price objective would suggest a potential upside of 19.54% from the stock’s current […]

P3 Health Partners (NASDAQ:PIII – Get Free Report) had its target price cut by analysts at TD Cowen from $8.00 to $3.00 in a research note issued on Thursday,Benzinga reports. The firm currently has a “hold” rating on the stock. TD Cowen’s price target would indicate a potential upside of 11.52% from the company’s current […]

Viridian Therapeutics (NASDAQ:VRDN – Get Free Report) had its target price lowered by equities researchers at Wedbush from $44.00 to $37.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Wedbush’s price objective would suggest a potential upside of 95.53% from the […]

AnaptysBio (NASDAQ:ANAB – Get Free Report) had its target price boosted by Piper Sandler from $67.00 to $95.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the biotechnology company’s stock. Piper Sandler’s price objective indicates a potential upside of 69.07% from the stock’s current price. ANAB […]

Arhaus (NASDAQ:ARHS – Get Free Report) had its price objective decreased by research analysts at TD Cowen from $12.00 to $9.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. TD Cowen’s target price points to a potential upside of 37.80% from […]